loperamide

(redirected from Lopex)
Also found in: Dictionary, Acronyms.

loperamide

 [lo-per´ah-mīd]
an agent used for its antiperistaltic action for treatment of diarrhea and reduction of the volume of discharge from ileostomies, administered orally.

loperamide

/lo·per·amide/ (lo-per´ah-mīd) an antiperistaltic used as the hydrochloride salt as an antidiarrheal and to reduce the volume of discharge from ileostomies.

loperamide

(lō-pĕr′ə-mīd′)
n.
A drug, C29H33ClN2O2, that inhibits intestinal motility and is used in the form of its hydrochloride to treat diarrhea.

loperamide

An antidiarrheal drug

loperamide

A synthetic narcotic analogue drug used to control mild diarrhoea. Brand names are Imodium and Norimode.

loperamide

a butyramide derivative; the hydrochloride is used as an antiperistaltic in the treatment of diarrhea.
References in periodicals archive ?
The pounds 11 million one-off windfall from Lopex boosted earnings after exceptionals by 204 per cent to 4.
Incepta was beaten by continental giant Havas to the acquisition of Lopex, but Mr Rodofsky said the purchase price paid by its rivals had looked a "bit peaky".
The 120p a share bid, which values Lopex at about pounds 67 million, represents a 39 per cent premium over the all-share offer made by Incepta on July 1.
Analysts pointed out that even if it lost out to Havas Incepta would walk away with a pounds 12 million profit on the Lopex shares it has already bought at between 30p and 40p each.
Lopex chief executive Mr Peter Thomas said Incepta's offer had flushed out ten other interested parties, but Havas was able to move quickly as it had previously run a ruler over the company.
9 per cent stake in Lopex at an average of 37p a share, Incepta has to decide whether to launch a more expensive bid or take the money and run.
Incepta chief executive, Mr David Wright, said he had hoped to announce a recommended offer next week after meeting Lopex directors on Monday.
Lopex is slightly smaller than Incepta, employs just under 900 people, and has a comprehensive regional network of offices including Birmingham - where its Grayling public relations subsidiary has an operation.
Analysts, however, have cut their profit forecasts for Lopex, reducing estimates from pounds 7.
The Sunday Telegraph: Land Securities (long-term hold), Tilbury Douglas (buy), Clinical Computing (buy), Charlton Athletic (worth a punt), Taylor Nelson (cash-in gains), Lopex (buy), Hercules Property Services (buy), Belhaven Brewery Group (now wellwort h a punt).